AzTrials
AzTrials

Patellofemoral Pain, PFPNCT07382037

Whole-Body Vibration in Patients With Patellofemoral Pain Syndrome

A study testing Whole body vibration in people with Patellofemoral Pain, PFP, run by Pamukkale University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patellofemoral Pain Syndrome (PFPS), or anterior knee pain, is one of the most common disorders affecting the lower extremities. Currently, there is no established "gold standard" treatment for PFPS. Read more about this study

Who is it for?
Ages 18 to 40 years
Conditions the study is for
Patellofemoral Pain, PFP
What is being tested?
Whole body vibration
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
39 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Jan 2026to 1 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Aged between 18 and 40 years,
  • Diagnosed with unilateral Patellofemoral Pain Syndrome (PFPS),
  • Reporting anterior knee pain or pain behind the patella in at least two of the following activities:
  • ascending stairs, jumping, running, squatting, kneeling, prolonged sitting,
  • Positive results in at least two of the following clinical tests: Eccentric step-down test, Patellar border tenderness test, Patellar grind (Clarke's) or apprehension test,
  • Ability to understand the procedures, potential benefits, and possible adverse effects,
  • Willingness to participate in the treatment program.

Who cannot join

  • Severe injury or pathological changes in knee structures (e.g., ligaments, menisci, patellar tendons, iliotibial bands, joint capsules, or plicae),
  • History of significant trauma or surgery involving the knee or lower extremity,
  • History of patellar dislocation or subluxation,
  • Diagnosis of Osgood-Schlatter disease or Sinding-Larsen-Johansson syndrome,
  • Joint effusion in the knee, or presence of redness, swelling, or increased warmth on physical examination,
  • Serious systemic conditions, including cardiovascular diseases, tumors, gallstones or kidney stones, severe disc or spinal lesions, pacemaker implantation, epilepsy, recent fractures or surgeries, or acute arthritis,
  • Pregnancy.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Pamukkale University

    Denizli, Pamukkale, 20160

Other trials in Turkey (Türkiye)

About this study

Official title: Efficacy of Whole-Body Vibration in Patients With Patellofemoral Pain Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Patellofemoral Pain Syndrome (PFPS), or anterior knee pain, is one of the most common disorders affecting the lower extremities.

Currently, there is no established "gold standard" treatment for PFPS. However, various interventions-including strengthening of the hip and knee muscles (e.g., hip abductors, external rotators, and knee extensors), taping, bracing, foot orthoses, manual therapy, acupuncture, blood flow restriction training, and conventional physical agents (e.g., ultrasound, cryotherapy, neuromuscular electrical stimulation, laser therapy, electromyographic biofeedback, etc.)-have been reported to provide meaningful clinical benefits. Strengthening of the hip and knee muscles alone has been shown to improve both pain and function in the short, medium, and long term. In recent high-quality studies, hip and knee muscle strengthening has been recognized as an effective "classical" treatment approach for PFPS. Regarding the mechanism of pain relief, previous research suggests that strengthening these muscles may alleviate pain by stabilizing patellar motion and/or reducing pressure on the patellofemoral joint.

Similar to traditional resistance training, whole-body vibration (WBV) training is an alternative method for muscle strengthening. WBV platforms can generate vertical vibrations that stimulate tonic vibration reflexes through muscle spindles, thereby activating homonymous alpha motor neurons and inducing reflex muscle contractions. As a result, increased motor unit recruitment enhances the excitability of muscle spindles, leading to improved muscle strength. Additionally, WBV training can improve muscle balance, strength, and function. Therefore, combining WBV with hip and knee strengthening exercises may represent a more effective treatment strategy for PFPS. The aim of this study is to evaluate whether the combination of WBV and hip-knee muscle strengthening is more effective in reducing pain and improving function than hip-knee strengthening alone.

Read the detailed description

Patellofemoral Pain Syndrome (PFPS), or anterior knee pain, is one of the most common disorders affecting the lower extremities.

Currently, there is no established "gold standard" treatment for PFPS. However, various interventions-including strengthening of the hip and knee muscles (e.g., hip abductors, external rotators, and knee extensors), taping, bracing, foot orthoses, manual therapy, acupuncture, blood flow restriction training, and conventional physical agents (e.g., ultrasound, cryotherapy, neuromuscular electrical stimulation, laser therapy, electromyographic biofeedback, etc.)-have been reported to provide meaningful clinical benefits. Strengthening of the hip and knee muscles alone has been shown to improve both pain and function in the short, medium, and long term. In recent high-quality studies, hip and knee muscle strengthening has been recognized as an effective "classical" treatment approach for PFPS. Regarding the mechanism of pain relief, previous research suggests that strengthening these muscles may alleviate pain by stabilizing patellar motion and/or reducing pressure on the patellofemoral joint.

Similar to traditional resistance training, whole-body vibration (WBV) training is an alternative method for muscle strengthening. WBV platforms can generate vertical vibrations that stimulate tonic vibration reflexes through muscle spindles, thereby activating homonymous alpha motor neurons and inducing reflex muscle contractions. As a result, increased motor unit recruitment enhances the excitability of muscle spindles, leading to improved muscle strength. Additionally, WBV training can improve muscle balance, strength, and function. Therefore, combining WBV with hip and knee strengthening exercises may represent a more effective treatment strategy for PFPS. The aim of this study is to evaluate whether the combination of WBV and hip-knee muscle strengthening is more effective in reducing pain and improving function than hip-knee strengthening alone.

Being tested
Whole body vibration, Sham Whole Body Vibration
Keywords
whole body vibration, knee
Medical subject headings
Patellofemoral Pain Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Whole body vibrationDevice

    In this group, prior to the patient stepping onto the platform, the practitioner will turn off the vibration motor of the device and activate an external motor (which is not in contact with the WBV device, has no effective vibration capability, and only produces sound), installed by our team. Since the visual display of the device remains active, patients will not be aware that the actual vibration function is disabled, thereby preventing any bias related to device inactivity.

  • Sham Whole Body VibrationDevice

    In this group, prior to the patient stepping onto the platform, the practitioner will turn off the vibration motor of the device and activate an external motor (which is not in contact with the WBV device, has no effective vibration capability, and only produces sound), installed by our team. Since the visual display of the device remains active, patients will not be aware that the actual vibration function is disabled, thereby preventing any bias related to device inactivity.

Study groups in NCT07382037
Study groupRoleWhat they receive
ExperimentalExperimentalWhole body vibration group, 3 days a week, 30 minutes a day for 8 weeks
Receives: Device: Whole body vibration
Sham groupSham comparatorSham-whole body vibration, 3 days a week, 30 minutes a day for 8 weeks
Receives: Device: Sham Whole Body Vibration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. VAS

    Pain is the most characteristic symptom in Patellofemoral Pain Syndrome (PFPS). After recording the duration of pain (in months) for each patient, pain intensity was assessed using the Visual Analog Scale (VAS), which is a 10-centimeter (cm) line anchored by 0 (no pain) and 10 (unbearable pain). Patients were asked to rate their pain at rest, during stair ascent/descent, squatting, prolonged sitting, and walking. Crossley et al. have reported that the VAS is a valid, reliable, and responsive tool for assessing pain in individuals with PFPS

    Measured: Change from baseline VAS at the 8th week after the treatment

Secondary outcomes (9)
  1. Anterior Knee Pain Scale

    Subjective symptoms and functional limitations of patients with Patellofemoral Pain Syndrome (PFPS) were evaluated using the Kujala Patellofemoral Scoring System. This scoring system was developed by Kujala et al. in 1993, and it allows for functional assessment of knee pathologies related to the patellofemoral structure. The Kujala Patellofemoral Pain Score consists of 13 subcategories evaluating limping, weight bearing, walking, stair activities, squatting, jumping, prolonged sitting with knees flexed at 90°, running, pain, swelling, abnormal painful patellar movement, thigh atrophy, and loss of flexion. The total score ranges from 0 to 100 points, with 100 indicating the best functional status.

    Measured: Change from baseline AKPS score at the 8th week after the treatment

  2. Short Form - 36

    The quality of life of all patients will be assessed using the Short Form-36 Health Survey (SF-36). This instrument consists of 36 items and measures eight health domains:

    Physical functioning (10 items), Social functioning (2 items), Role limitations due to physical problems (4 items), Role limitations due to emotional problems (3 items), Mental health (5 items), Energy/vitality (4 items), Bodily pain (2 items), and General health perception (5 items)

    Measured: Change from baseline SF-36 score at the 8th week after the treatment

  3. Muscle Mass Assessment via Ultrasound

    Muscle mass measurements of the vastus medialis and gluteus medius muscles will be performed using ultrasound (Clarius™ by Clarius Mobile Health) both before and after treatment.

    For the vastus medialis, the patient will be positioned supine with the knee in approximately 30 degrees of flexion. The ultrasound probe will be placed on the medial quadriceps region, between the medial border of the patella and the medial femoral condyle. The probe will be angled at approximately 45° to the long axis of the femur, oriented parallel to the muscle fibers.

    For the gluteus medius, the patient will be positioned in side-lying, with the painful side facing upward. The probe will be placed at the lower half of the distance between a line connecting the anterior superior iliac spine (ASIS) and the posterior superior iliac spine (PSIS) and the greater trochanter.

    Measurements will be performed by the same evaluator at baseline and at the 8th week following treatment.

    Measured: Change from baseline muscle mass assessment at the 8th week after the treatment

  4. Change in peak torque at 60°/s (Nm) of the knee muscles measured by isokinetic dynamometer

    Isokinetic assessment of the symptomatic (painful) knee will be performed using the IsoMed 2000 Isokinetic System. Participants will be seated in an upright position with stabilization of the trunk and lower limbs. Peak Torque (PT, measured in Newton-meters, Nm) represents the maximum torque generated during knee flexion and extension at an angular velocity of 60°/s. Participants will perform four maximal repetitions following three familiarization trials. The change in PT from baseline to week 8 will be used to assess improvement in knee muscle endurance at higher movement speeds.

    Measured: Change from baseline to Week 8 after treatment

  5. Change in peak torque at 240°/s (Nm) of the knee muscles measured by isokinetic dynamometer

    Isokinetic assessment of the symptomatic (painful) knee will be performed using the IsoMed 2000 Isokinetic System. Participants will be seated in an upright position with stabilization of the trunk and lower limbs.

    Peak Torque (PT, measured in Newton-meters, Nm) represents the maximum torque generated during knee flexion and extension at an angular velocity of 240°/s. Participants will perform ten maximal repetitions following three familiarization trials.

    The change in PT from baseline to week 8 will be used to assess improvement in knee muscle endurance at higher movement speeds.

    Measured: Change from baseline to Week 8 after treatment

  6. Assessment of the hamstring/quadriceps ratio at 60°/s with an isokinetic dynamometer

    The H/Q ratio will be calculated using the peak torque values obtained from the isokinetic tests at 60°/s.

    Specifically, it is determined by dividing the hamstring peak torque by the quadriceps peak torque measured during the same test session.

    The H/Q ratio at this slower speed reflects the strength balance between the knee flexors and extensors under controlled movement conditions.

    A balanced ratio is crucial for joint stability and injury prevention, particularly in patients with knee pain or dysfunction.

    Testing will be conducted using the IsoMed 2000, with the patient's position and stabilization identical to other isokinetic assessments.

    Measured: Change from baseline VAS at the 8th week after the treatment

  7. Assessment of the hamstring/quadriceps ratio at 240°/s with an isokinetic dynamometer

    The H/Q ratio will also be calculated at 240°/s, based on the peak torque values obtained from the high-velocity isokinetic test.

    It is computed by dividing the hamstring peak torque by the quadriceps peak torque at this higher angular velocity.

    The H/Q ratio at 240°/s assesses the dynamic balance and neuromuscular coordination between flexor and extensor muscle groups during rapid movements.

    Maintaining an appropriate H/Q ratio at faster speeds is considered an important indicator of functional knee stability and injury resilience.

    All procedures (positioning, stabilization, familiarization, and repetitions) will be performed identically to the other isokinetic test conditions, using the IsoMed 2000 system.

    Measured: Change from baseline to week 8 after treatment

  8. Change in Total Work (J) of the Knee Muscles at 60°/s With an Isokinetic Dynamometer

    Isokinetic assessments of the symptomatic (painful) knee will be performed using the IsoMed 2000 Isokinetic System. Participants will be seated in an upright position, with the chest, waist, and lower limbs secured to ensure proper body stabilization and minimize compensatory movements.

    To obtain reliable data on muscle performance, testing at an angular velocity of 60°/s will include four consecutive maximal concentric repetitions of knee flexion and extension. Prior to the test, participants will perform three familiarization repetitions at the same velocity to become accustomed to the movement and the device.

    Total Work (TW), measured in Joules (J), represents the total amount of work performed by the knee flexor and extensor muscles across all repetitions at 60°/s.

    This parameter reflects overall muscular endurance and energy output of the quadriceps and hamstrings during slower, controlled movements.

    Measured: Change from baseline to Week 8 after treatment

  9. Change in Total Work (J) of the Knee Muscles at 240°/s With an Isokinetic Dynamometer

    Isokinetic assessments of the symptomatic (painful) knee will be conducted using the IsoMed 2000 Isokinetic System. Participants will be positioned in an upright seated position, and the chest, waist, and lower limbs will be secured with straps to ensure body stabilization during testing.

    For this evaluation, an angular velocity of 240°/s will be used, and patients will perform ten consecutive maximal concentric repetitions of knee flexion and extension. Before the test, three familiarization repetitions at the same angular velocity will be completed to ensure accurate and consistent performance.

    Total Work (TW), expressed in Joules (J), will represent the total energy output of the knee flexor and extensor muscles during all repetitions at 240°/s.

    This measurement provides information on muscular endurance, power, and performance efficiency of the knee muscles under high-velocity dynamic conditions.

    Measured: Change from baseline to Week 8 after treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Feb 2026
  2. Study start15 Jan 2026
  3. Primary completion15 May 2026
  4. Study completion1 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
39 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07382037
Sponsor's protocol ID
PamukkaleU.ftr-HAlkan-001
Status last verified
Aug 2026
First submitted
9 Aug 2025
Last updated
21 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Dag F, Dal U, Altinkaya Z, Erdogan AT, Ozdemir E, Yildirim DD, Colak M. Alterations in energy consumption and plantar pressure distribution during walking in young adults with patellofemoral pain syndrome. Acta Orthop Traumatol Turc. 2019 Jan;53(1):50-55. doi: 10.1016/j.aott.2018.10.006. Epub 2018 Oct 25.

    PubMed 30482589
  • Corum M, Basoglu C, Yakal S, Sahinkaya T, Aksoy C. Effects of whole body vibration training on isokinetic muscular performance, pain, function, and quality of life in female patients with patellofemoral pain: a randomized controlled trial. J Musculoskelet Neuronal Interact. 2018 Dec 1;18(4):473-484.

    PubMed 30511951
  • Dieterich AV, Pickard CM, Strauss GR, Deshon LE, Gibson W, McKay J. Muscle thickness measurements to estimate gluteus medius and minimus activity levels. Man Ther. 2014 Oct;19(5):453-60. doi: 10.1016/j.math.2014.04.014. Epub 2014 May 10.

    PubMed 24880207
  • Dogan A, Sengul I, Askin A, Tosun A. Effect of static knee joint flexion on vastus medialis obliquus fiber angle in patellofemoral pain syndrome: An ultrasonographic study. PM R. 2022 Jul;14(7):802-810. doi: 10.1002/pmrj.12655. Epub 2021 Jul 23.

    PubMed 34165244
  • Kuru T, Dereli EE, Yaliman A. Validity of the Turkish version of the Kujala patellofemoral score in patellofemoral pain syndrome. Acta Orthop Traumatol Turc. 2010;44(2):152-6. doi: 10.3944/AOTT.2010.2252.

    PubMed 20676018
  • Kujala UM, Jaakkola LH, Koskinen SK, Taimela S, Hurme M, Nelimarkka O. Scoring of patellofemoral disorders. Arthroscopy. 1993;9(2):159-63. doi: 10.1016/s0749-8063(05)80366-4.

    PubMed 8461073
  • Takanashi Y, Chinen Y, Hatakeyama S. Whole-body vibration training improves the balance ability and leg strength of athletic throwers. J Sports Med Phys Fitness. 2019 Jul;59(7):1110-1118. doi: 10.23736/S0022-4707.18.09012-6. Epub 2018 Oct 10.

    PubMed 30317837
  • Alam MM, Khan AA, Farooq M. Effect of whole-body vibration on neuromuscular performance: A literature review. Work. 2018;59(4):571-583. doi: 10.3233/WOR-182699.

    PubMed 29733043
  • Petersen W, Rembitzki I, Liebau C. Patellofemoral pain in athletes. Open Access J Sports Med. 2017 Jun 12;8:143-154. doi: 10.2147/OAJSM.S133406. eCollection 2017.

    PubMed 28652829
  • Crossley KM, Callaghan MJ, van Linschoten R. Patellofemoral pain. Br J Sports Med. 2016 Feb;50(4):247-50. doi: 10.1136/bjsports-2015-h3939rep.

    PubMed 26834209
  • Ho KY, Keyak JH, Powers CM. Comparison of patella bone strain between females with and without patellofemoral pain: a finite element analysis study. J Biomech. 2014 Jan 3;47(1):230-6. doi: 10.1016/j.jbiomech.2013.09.010. Epub 2013 Oct 15.

    PubMed 24188973
  • Cheung RT, Zhang Z, Ngai SP. Different relationships between the level of patellofemoral pain and quality of life in professional and amateur athletes. PM R. 2013 Jul;5(7):568-72. doi: 10.1016/j.pmrj.2012.12.007. Epub 2013 Jan 29.

    PubMed 23375635
  • Smith BE, Selfe J, Thacker D, Hendrick P, Bateman M, Moffatt F, Rathleff MS, Smith TO, Logan P. Incidence and prevalence of patellofemoral pain: A systematic review and meta-analysis. PLoS One. 2018 Jan 11;13(1):e0190892. doi: 10.1371/journal.pone.0190892. eCollection 2018.

    PubMed 29324820
  • Dey P, Callaghan M, Cook N, Sephton R, Sutton C, Hough E, James J, Saqib R, Selfe J. A questionnaire to identify patellofemoral pain in the community: an exploration of measurement properties. BMC Musculoskelet Disord. 2016 May 31;17:237. doi: 10.1186/s12891-016-1097-5.

    PubMed 27245443
  • Willy RW, Hoglund LT, Barton CJ, Bolgla LA, Scalzitti DA, Logerstedt DS, Lynch AD, Snyder-Mackler L, McDonough CM. Patellofemoral Pain. J Orthop Sports Phys Ther. 2019 Sep;49(9):CPG1-CPG95. doi: 10.2519/jospt.2019.0302.

    PubMed 31475628

Questions about this trial

What is this clinical trial studying?

A study testing Whole body vibration in people with Patellofemoral Pain, PFP, run by Pamukkale University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

VAS (time frame: Change from baseline VAS at the 8th week after the treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07382037, which also lists 15 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in